Patent holdings for IPC class A61P 13/02

Total number of patents in this class: 641

10-year publication summary

11
34
33
45
45
33
43
29
29
10
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Astellas Pharma Inc.
1049
26
Takeda Pharmaceutical Company Limited
2713
18
Kissei Pharmaceutical Co., Ltd.
177
16
ASKA Pharmaceutical Co., Ltd.
103
12
Shionogi & Co., Ltd.
827
10
Nippon Shinyaku Co., Ltd.
328
9
Ono Pharmaceutical Co., Ltd.
426
9
Sumitomo Dainippon Pharma Co., Ltd.
211
9
Taisho Pharmaceutical Co., Ltd.
863
9
Dainippon Sumitomo Pharma Co., Ltd.
176
8
KYORIN Pharmaceutical Co., Ltd.
167
8
Mochida Pharmaceutical Co., Ltd.
335
8
The Kitasato Institute
159
7
Nippon Chemiphar Co., Ltd.
227
7
The Regents of the University of California
20410
6
Lakewood-amedex, Inc.
31
6
Tohoku University
2879
6
Kobayashi Pharmaceutical Co., Ltd.
776
5
Meiji Seika Pharma Co., Ltd.
254
5
Novartis AG
10463
4
Other owners 453